Strength

Chen Yue
Chen Yue
Chairman Founder and new drug inventor

2016 National Outstanding Youth Fund, Tianjin Outstanding Talent, Tianjin Science and Technology Invention First Prize. Professor and doctoral supervisor, School of Chemistry, Nankai University.

Wang Peng
Wang Peng
Director and co-founder

Cheung Kong Scholar, American President's Award for Green Chemistry, Hudson Award winner. Professor, PhD supervisor, Southern University of Science and Technology.

He Ruyi
He Ruyi
Chief scientific advisor to the company

Former senior reviewer of the US Food and Drug Administration, former Chief Scientist of the CDE of the China Food and Drug Administration, participated in the development of FDA guidelines in multiple therapeutic areas, and played a major role in global registration and domestic clinical application/international multi-center clinical.

Cai Dongpo
Cai Dongpo
The company's chief medical officer

Having nearly complete experience in the development of anti-cancer drugs that span across basic research, translational medicine, and clinical phases one and two. Early clinical drug development involving multiple important targets and tumor immune targets. From 2012 to 2015, served as Vice Chairman of the Chinese Experts and Scholars Association at Harvard Medical School, responsible for translational and precision medicine activities. Having years of clinical experience in China and understanding the Chinese clinical system.

Lin Qinghong
Lin Qinghong
Corporate vice president

Mainly engaged in pharmaceutical product development and production and drug registration technology and standardized management work. I have accumulated rich practical experience in the research and development and registration of pharmaceutical products, the pharmaceutical policies and standardized management of European and American countries, and am familiar with the pharmaceutical administration regulations and pharmaceutical intellectual property regulations of Europe, America and Australia. I have participated in the GMP audit of the production site of the US FDA and the UK MHRA for many times, and I have experience in drug quality management and coordination of global pharmaceutical projects.

Su Yongchang
Su Yongchang
Corporate vice president

Formerly served as the project leader for the AAALAC international certification of experimental animal facilities at NHRI (National Institutes of Health) in Taiwan/Special Assistant to the General Manager's Office of Medtronics. Senior Researcher at the Institute for Glycomics Research and Development Center at the University of Griffith, Australia, Lecturer and Researcher at the Department of Biomedical Sciences at the University of Queensland, Australia, and Postdoctoral Researcher at the University of Canberra, Australia.